{"title":"痛风患者的动脉高压:病原体基础,临床意义,诊断","authors":"E. I. Markelova, M. S. Eliseyev, V. G. Barskova","doi":"10.14412/1996-7012-2012-759","DOIUrl":null,"url":null,"abstract":"Cardiovascular diseases (CVD) caused by vascular atherosclerotic lesion are the leading cause of death in gout patients. Analysis of the data available in the literature has indicated that monitoring blood pressure and target organ damage thoroughly serves as the basis for the prevention of CVD and cardiovascular catastrophes in patients with gout.","PeriodicalId":36215,"journal":{"name":"Sovremennaya Revmatologiya","volume":"6 1","pages":"23-30"},"PeriodicalIF":0.0000,"publicationDate":"2012-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Артериальная гипертензия у больных подагрой: основы патогенеза, клиническое значение, диагностика\",\"authors\":\"E. I. Markelova, M. S. Eliseyev, V. G. Barskova\",\"doi\":\"10.14412/1996-7012-2012-759\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Cardiovascular diseases (CVD) caused by vascular atherosclerotic lesion are the leading cause of death in gout patients. Analysis of the data available in the literature has indicated that monitoring blood pressure and target organ damage thoroughly serves as the basis for the prevention of CVD and cardiovascular catastrophes in patients with gout.\",\"PeriodicalId\":36215,\"journal\":{\"name\":\"Sovremennaya Revmatologiya\",\"volume\":\"6 1\",\"pages\":\"23-30\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2012-12-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Sovremennaya Revmatologiya\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.14412/1996-7012-2012-759\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sovremennaya Revmatologiya","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14412/1996-7012-2012-759","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
Артериальная гипертензия у больных подагрой: основы патогенеза, клиническое значение, диагностика
Cardiovascular diseases (CVD) caused by vascular atherosclerotic lesion are the leading cause of death in gout patients. Analysis of the data available in the literature has indicated that monitoring blood pressure and target organ damage thoroughly serves as the basis for the prevention of CVD and cardiovascular catastrophes in patients with gout.